SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
HONG KONG, Dec. 16, 2025 /PRNewswire/ -- Asia's leading data-driven AdTech ecosystem, PressLogic, today officially announces the full acquisition of Baby-Kingdom, one of Hong Kong's most...
- Contributing to Sustainable Society through Tree Planting Activities and Resource Recovery - TOKYO, Dec. 16, 2025 /PRNewswire/ -- Nippon Express (Taiwan) Co.,...